Listeners:
Top listeners:
High Blood Pressure Can Quietly Damage Your Heart
Your Arteries Might Be Aging Faster Than You
The Biggest Lie About Statins Is Putting Lives at Risk
The Most Dangerous Symptom Is Silence
He Smiled Every Day. Nobody Knew He Was Depressed
Opioid Laws Hurt Some Patients More Than Others
Weight Loss Episode 12 months ago 0 Like
play_arrow
PLAY EPISODE
You finally found something that works. The weight is coming off. Your blood sugar is better. But
instead of support, you’re being judged-even by your own community.
In this episode of the AfroFit Podcast, Dr. Takem confronts the shame, guilt, and misinformation
surrounding GLP-1 medications like Ozempic, Wegovy, and Mounjaro-especially in Black
communities where “struggle culture” runs deep.
We break down:
– What GLP-1s actually do (and what they don’t)
– Why Black people are being shamed for getting healthy
– The real reason fitness influencers, doctors, and even family are attacking these meds
– How to separate cultural guilt from medical facts
– Why shame is the heaviest weight of all
This episode is not about pills. It’s about truth, healing, and freedom.
Ready to stop hiding and start healing?
Watch now. Then share this with someone who needs to WAKE UP.
Subscribe to the AfroFit Podcast for unfiltered truth about Black wellness, weight loss, and mental
health.
Download our free African and American Diet Guides here: https://afrofit.btsdrtakem.com
Follow @AfroFitPodcast on all platforms
💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://marylandprimarycare.com
0 4 days ago
0 6 days ago
We tackle the health topics no one else wants to touch
—From obesity and high blood pressure
—To emotional eating and medication resistance
—To cultural myths that keep people sick
My mission is to deliver evidence-based truth—no sugarcoating, culture-aware, and guided by medicine.
© Dr Albert Takem
Are you sure you want to cancel your subscription? You will lose your Premium access and stored playlists.
✖
Be the first to leave a comment